CURRICULUM VITAE

Mohsen Sharifi, MD, FACC, FSCAI, FSVM

Clinical Professor, A.T. Still University

Director, Arizona Cardiovascular Consultants & Vein Clinic

E-mail: seyedmohsensharifi@yahoo.com

Cell phone: (480) 577 2421

Office : (480) 924 0006

Licensure:

Arizona# 33949

Board Certification :

2011, American Board of Vascular Medicine

1999, ABIM Certification in Interventional Cardiology

1997, ABIM Certification in Cardiovascular Medicine

1993, ABIM Certification in Internal Medicine ( Expired 2013)

1996, Certification Board of Nuclear Cardiology

1996, Licensure, Nuclear Regulatory Commission ( NRC )

Faculty at:

American College of Cardiology

Society for Cardiovascular Angiography and Interventions

Society for Vascular Medicine

Trans-Catheter Therapeutics

New Cardiovascular Horizons

VEITH Symposium

International Symposium on Endovascular Therapy

International Congress on Endovascular Interventions

Comprehensive Arterial & Vascular Endovascular Course (CVC)

PROFESSIONAL

EXPERIENCE:

6/2005- Present

Private Practice

Director & Founder Arizona Cardiovascular Consultants & Vein Clinic

Mesa, AZ

4/2011-Present

Clinical Professor

AT Still University- School of Osteopathic Medicine

Meza, AZ

2006- 2011

Clinical Associate Professor

AT Still University- School of Osteopathic Medicine

Meza AZ

5/2003- 5/2005

Associate Professor of Medicine

Chief, Section of Cardiology,

Director, Cardiovascular Interventions

Texas Tech University Health Sciences Center, Odessa, TX

9/ 2000-5/2003 Clinical Assistant Professor

Case Western Reserve University &

The University Hospitals of Cleveland, Cleveland, Ohio

9/1999- 9/2000 Staff Cardiologist

Winona Hospital

Indianapolis, IN

7/1996- 6/1998 Staff Cardiologist

Wausau Hospital

President, Cardiocare ltd.

Wausau WI

Post Graduate

Training:

1998 - 1999 Interventional Cardiology

Indiana University School of Medicine,

Krannert Institute of Cardiology

1993 - 1996 Cardiology Fellowship

University of Chicago, Lutheran General Hospital,

Park Ridge, Illinois

1991 - 1993 Residency, Internal Medicine

Northwestern University Medical School,

Evanston Hospital, Evanston, Illinois

1990-1991 Internship, Internal Medicine

MacNeal Hospital– Rush University

Berwyn, Illinois

Medical Schools:

1983-1989

Shahid Beheshti University , Tehran – Iran

(National University of Iran)

1989-1990

Ross University, Edison, N.J.

Specialized

Training:

Peripheral Vascular & Endovenous Interventions

Venous ablation, Microphlebectomy, Sclerotherapy

Interventional Cardiology: PTMC, PFO & ASD Closures

Nuclear Cardiology (NRC License and CBNC Certification, Level III

Training)

Coronary CT Angiography Level II Training

Awards:

Award Recipient, American College of Cardiology

Fifth Annual Meeting. Chicago, Illinois, December 1995

Bronchial Arteriovenous Malformation

First Place Award, American College of Cardiology

Fourth Annual Meeting, Chicago, Illinois, October 1994

Complications of Left Ventricular Pacing.

Research:

Primary Investigator- APEX trial

Principal Investigator, Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention

in Deep venous Occlusion (TORPEDO trial).

Principal Investigator , FILTER- PEVI Trial.

Principal Investigator, EVISTA-DVT Trial.

Principal Investigator, MOPETT Trial.

Principal Investigator, Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions,

(HOT-PI)

Site Investigator, CRUSCADE trial

Site Investigator, ACUTE II trial

Reviewer for: Chest

Catheterization and Cardiovascular Interventions

Cochrane Library

Professional Societies:

Society for Coronary Angiography and Interventions (SCAI)

American College of Cardiology

Society for Vascular Medicine

Languages Spoken: Spanish, French, German, Farsi

Committee Member:

Society of Vascular Medicine

Society for Coronary Angiography and Interventions (SCAI)- PAD

Medical Consultant:

Arizona Board of Medicine

Medical Mutual of Ohio

ACCEL Interview:

Moderate Pulmonary Embolism Treated with Thrombolysis; Vol 44, No.12, December 2012.

Book Chapters:

Sharifi M. Percutaneous Endovenous Intervention in Femoropopliteal Deep Venous

Thrombosis. Chapter 54; Atlas of Vascular Medicine. McGraw Hill, 2013.

Journal Publications:

Sharifi M. Systemic full dose, half dose and catheter directed thrombolysis for pulmonary

embolism. When to use and how to choose? Curr Treat Options Cardio Med 18:31 Feb ,2016.

Sharifi M, Berger J, Beeston P et al. Pulseless Electrical Activity in Pulmonary Embolism

Treated with Thrombolysis, (From the "PEAPETT" Study). Am J Emerg Med (In press).

Sharifi M, Vajo Z , Freeman W et al. Transforming and Simplifying the Treatment of

Pulmonary Embolism: "Safe Dose" Thrombolysis Plus New Oral Anticoagulants. LUNG

193:369-74 2015.

Sharifi M. Optimal Treatment of Submassive Pulmonary Embolism. http://www.acc.org.

September 15, 2015.

Sharifi M, Bay C, Vajo Z. et al. New Oral Anticoagulants in the Treatment of Heparin- Induced

Thrombocytopenia. Thrombosis Research 2015 Apr;135(4):607-9

Sharifi M, Freeman W, Bay C, et al. Low Incidence of Post-Thrombotic Syndrome in Patients

Treated with New Oral Anticoagulants and Percutaneous Endovenous Intervention for Lower

Extremity Deep Venous Thrombosis. Vasc Med April 2015.

Sharifi M. Modern Management of Acute Deep Venous Thrombosis.

Vasc Dis Mgmt 11: E2-E11; 2014.

Sharifi M, Bay C, Schwartz F, Skrocki L. "Safe Dose Thrombolysis" plus Rivaroxaban in the

Treatment of Moderate and Severe Pulmonary Embolism: "Drip, Drug, and Discharge".

Clinical Cardiology 37: 78082; 2014.

Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate Pulmonary Embolism

Treated with Thrombolysis: The "MOPETT" Trial. Am J Cardiol 111: 273- 277, 2013.

Sharifi M Naming the Magnitude of the Final Pulmonary Artery Systolic Pressure is in the

Eye of the Beholder ( letter). Am J Cardiol 111: 1831, 2013.

Sharifi M, Bay C, Nowroozi S, Bentz S, Valeros G, Catheter Directed Thrombolysis with

Argatroban and tPA for Extensive Iliac and Femoropopliteal Vein Thrombosis.

Cardiovasc Interv Rad 36: 1586-159, 2013.

Sharifi M, Bay C, Mehdipour M, Sharifi J.Thrombus Obliteration by Rapid Percutaneous

Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial: Mid-term Results. J

Endovas Therapy 19:273–280, 2012.

Sharifi M, Bay C, Skrocki L, Lawson D, Mazdeh S. Role of IVC Filters in Endovenous

Therapy for Deep Venous Thrombosis: The FILTER-PEVI Trial. Cardiovasc Interv Rad

35:1408–1413, 2012.

Sharifi M, Javadpour S, Bay C, Mehdipour M, Emrani F, Sharifi J. Outcome of Stenting in

the Lower Extremity Venous Circulation for the Treatment of Deep Venous Thrombosis.

Vasc Dis Mgmt 7: 233-239, 2010

Sharifi M, Mehdipour M, Bay C, Emrani F, Sharifi J. Effect of anticoagulation on

endothermal ablation of the great saphenous vein. J Vasc Surg 53: 147-149 2011.

Sharifi M, Mehdipour M, Bay C, Smith G, Sharifi J. Endovenous Therapy for Deep Venous

Thrombosis : The TORPEDO Trial. Catheteriz Cardiovasc Interv 2010; 76:316-325

Sharifi M, Mehdipour M. Percutaneous Therapy of Acute on Chronic Lower Extremity

Venous Occlusive Disease. Catheteriz Cardiovasc Interv 75:685-689,2010.

Sharifi M, Mehdipour M, Skloven D, et al. Power Pulse Spray and Angiojet Thrombectomy

in Massive Inferior Vena Cava and Bilateral Lower Extremity Deep Venous Thrombosis.

Vasc Dis Mgmt 5:62-65,2008.

Sharifi M, Parhizgar A, Gupta P, Mehdipour M. et al. Is Transesophageal Echocardiography

Necessary before D.C. Cardioversion in Patients with a Normal Transthoracic

Echocardiogram? Echocardiography 24:397-400, 2007.

Sharifi M, Parhizgar A, Mehdipour M et al. Percutaneous Balloon Aortic Valvuloplasty: A

new look at an old procedure. Angiology 57:724-728, 2007.

Sharifi M, Dehghani M, Mehdipour M, Al-Bustami O, Burks J. Intense migraines secondary

to percutaneous closure of atrial septal defects. J Interv Cardiol 18:181-183, 2005.

Sharifi M, Fares W, Abdel-Karim I et al. The Usefulness of Hyperbaric Oxygen Therapy to

Inhibit Restenosis in Percutaneous Coronary Interventions after Acute Myocardial Infarction

and Unstable Angina Pectoris. Am J Cardiol 93:1533-1535, 2004.

Sharifi M, Burks J. Efficacy of Clopidogrel in the Treatment of Post-ASD Closure

Migraines. Catheteriz Cardiovascular Interven 2004 ,63:255.

Sharifi M, Inbar S, Neckels , Shook H. Twiddling to the extreme: Development of Twiddler

syndrome in an ICD. J Invasive Cardiol 17: Feb 2005.

Bustami O, Sharifi M, Hijazi Z Necessity for evaluation of partial anomalous pulmonary

venous return prior to percutaneous closure of interatrial shunts in adults. Angiology 56:647-

650, 2005.

Bourdillon P,Von der Lohe E, Lewis SJ, Sharifi M et al. Comparison of Left

Ventriculography and Coronary Arteriography with Positron Emission Tomography in

Assessment of Myocardial Viability. Clin Cardiol 26:60-66,2003.

Fares W, Sharifi M, Sawaf N.et al. Superior Vena Cava Syndrome Secondary to Saphenous

Vein Graft Aneurysm with Right Atrial Fistula. Catheter Cardiovascular Interventions

60:45-47,2003.

Sharifi M, Fares W, Abdel-Karim I et al. Inhibition of Restenosis by Hyperbaric Oxygen: A

Novel Indication for an old Modality. Cardovasc Rad Med.3:124-126,2003

Sharifi M, Koch JM, Steele RJ et al. Third Degree AV Block Due to Ophthalmic Timolol

Solution. Internat J Cardiol 80: 257-259, 2001.

Sharifi M, Koch M , Steele R et al. Pace but with Grace. Catheteriz Cardiovascular Interven

52: 535,2001.

Sharifi M, Siraj Y, O’Donnell J et al. Coronary Angioplasty and Stenting in Orthotopic

Heart Transplants: A Fruitful Act or a Futile Attempt? Angiology 51: 809-815, 2000.

Sharifi M, Dillon JC, Pompili VJ. Saphenous Vein Graft Ectasia.An Unusual Complication

of Coronary Artery Bypass Surgery. Angiology 50: 497-501, 1999.

Sharifi M. Turrentine MW, Mahomed Y et al. Left Internal Mammary Artery Graft

Perforation Secondary to High Pressure Stent Deployment. Catheteriz Cardiovascular

Interven 47: 199 – 202, 1999.

Sharifi M, Lauer J, Pompili V, Dillon J. Arteriography of the left internal mammary artery

graft using a balloon tipped floatation catheter: An alternative approach J Invasive Cardiol

11:682-684, 1999.

Sharifi M, Pompili VJ, Dillon JC. Manual Assembly of a Retrieval System for Retained

Objects in the Coronary Circulation. Internat J Cardiol 71: 85-86,1999.

Sharifi M, Murdock DK, Engelmeier RS et al. Simultaneous Presence of a Large Coronary

Artery Aneurysm and Ectasia in a Young Patient With Myocardial Infarction. Angiology 48:

1001 - 1005, 1997.

Sharifi M, Khedkar N, Peller P et al. First Pass Tc-99 M Mibi Ventriculography in the

assessment of left ventricular diastolic function -A Comparison With Doppler

Echocardiography. Clin Nuc Med 21: 679 - 684,1996.

Sharifi M, Sorkin R, Lakier JB. Left Ventricular Pacing: A Fact, Not an Artifact. Am J

Cardiol(letter) P.379,1996.

Sharifi M, Messersmith R, Newman B et al. Bronchial Arteriovenous Malformation in a

Child with Hemoptysis. Angiology 47: 203 - 209, 1996.

Sharifi M, Sorkin R, Lakier J. Inadvertent Malposition of Transvenous Inserted Pacing

Leads in the Left Ventricular Chamber. Am J Cardiol 76: 92 - 95, 1995.

Sharifi M, Frohlich TG, Silverman IM. Myocardial Infarction With Angiographically

Normal Coronary Arteries. Chest 107: 36 - 44, 1995.

Sharifi M, Sorkin R, Lakier J. Left Heart Pacing and Cardioembolic Stroke. PACE 17: 1691

- 1696, 1994.

Sharifi M, Sorkin R, Lakier J. Intraaortic Thrombosis as a Cause of Bowel Ischemia.

Angiology 45: 973 - 977,1994.

Sharifi M. Digoxin Induced Abdominal Pain in a Patient Undergoing Maintenance

Hemodialysis. Am J Nephrol 11: 409 - 10, 1991.

ABSTRACTS

Sharifi M, Davies M Freeman W, et al. Role Of Wallstents In The Treatment Of Chronic

Inferior Vena Cava Filter Occlusion J Am Coll Cardiol. 2015;66;15S.

Sharifi M, Berger J, Davies M, et al. Treatment of Massive Pulmonary Embolism During

Cardio- Pulmonary Collapse and Pulseless Electrical Activity With Low Dose Systemic

Thrombolysis. Vascular Medicine. 2016, Vol. 21(3), 305-306.

Sharifi M, Baqdunes W, Berger J, et al. Abdominal Aortic Endoluminal Grafts and

Subsequent Abdominal Surgery Promotes Extensive Deep Vein Thrombosis. Catheterization

and Cardiovascular Interventions. Supplmt, 87: S 45, April 2016.

Sharifi M, Baqdunes W, Berger J, et al. Outcome of Life Star Stents in the Venous

Circulation .Catheterization and Cardiovascular Interventions. Supplmt, 87: S 46, April 2016.

Sharifi M, Ostrue J, Carey E, Freeman W. Role of New Oral Anticoagulants in the

Treatment of Superficial Venous Thrombosis of the Lower Extremities. Vascular Medicine.

2014, Vol. 19(3).

Sharifi M, Freeman W, Davies M et al. Treatment of IVC Filter Chronic Occlusions with

Wall Stents. Catheterization and Cardiovascular Interventions. 85: S 52, May 2015.

Sharifi M, Freeman W, Jiminez J et al. Role of Apixaban in Dialysis Patients after PEVI for

DVT of Lower Extremities.Vasc Med 20:299; 2015.

Sharifi M, Freeman W, Bay C et al. Percutaneous Endovenous Intervention Plus New Oral

Anticoagulants in Cancer Patients with Lower Extremity Deep venous Thrombosis. JACC

March 17, 2015 A 523, 1258-333

Sharifi M, Freeman W, Bay C, Sharifi M, Breed C, Schwartz F. Treatment of Heparin

Induced Thrombocytopenia with New Oral Anticoagulants. J Am Coll Cardiol. 2014;

63(12_S).

Sharifi M, Freeman W, Bay C, Sharifi M, Breed C, Schwartz F. Paradigm Shift in the

Treatment of Pulmonary Embolism: Safe Dose Thrombolysis Plus Rivaroxaban. J Am Coll

Cardiol. 2014; 63(12_S):. doi:10.1016/S0735-1097(14)61476-5

Sharifi M, Freeman W, Bay C, Sharifi M, Schwartz F. Percutaneous Endovenous

Intervention and New Oral Anticoagulants Reduce Post-Thrombotic Syndrome in Acute

Deep Venous Thrombosis. Catheterization and Cardiovascular Interventions. May

2014.Volume 83.Issue Supplement S1 (S64-65). doi:10.1002/ccd.

Sharifi M, Carey E, Mafi N, Freeman W, Sharifi M. Limited Role of Thrombectomy

Devices Alone for Occlusive IVC Filter Thrombosis. Catheterization and Cardiovascular

Interventions. May 2014.Vol.83.Issue Supplement S1 (S80-81).

Sharifi M, Ostrue J, Carey E, Freeman W. Role of New Oral Anticoagulants in the

Treatment of Superficial Venous Thrombosis of the Lower Extremities. Vascular Medicine.

2014, Vol. 19(3). doi:10.1177/1358863X14533477

Sharifi M, Freeman W, Camiliere T, Vajo Z, Bay C, Sharifi M, Schwartz F. New Oral

Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for

Lower Extremity Deep Venous Thrombosis. J Am Coll Cardiol. 2014; 64(11_S):.

doi:10.1016/j.jacc.2014.07.532.

Sharifi M, Klyn S, Carroll K, et al. Treatment of Occlusive IVC Filter Thrombosis by

Percutaneous Endovenous Intervention. Catheteriz Cardiovasc Interv Supplement 1, 81:S

67-8;2013.

Sharifi M, Klyn S, Skrocki L, et al. Role of Rivaroxaban in Patients Undergoing

Percutaneous Endovenous Intervention for Massive Lower Extremity Deep Venous

Thrombosis. Catheteriz Cardiovasc Interv Supplement 1, 81:S 68;2013.

Sharifi M, Freeman W, Emami T, Chatham J, Schwartz F. Reduction of Hospitalization and

Duration of Anticoagulation for Deep Venous Thrombosis in Patients Undergoing

Percutaneous Endovenous Intervention and Receiving Novel Anticoagulants. J Am Coll

Cardiol. 2013; 62(18_S1):B157-B157. doi:10.1016/j.jacc.2013.08.1263

Sharifi M, Freeman W, Chatham J, Emami T, Bay C, Schwartz F. Argatroban and t-PA

During Catheter-Directed thrombolysis for Extensive lower Extremity Deep Venous

Thrombosis. J Am Coll Cardiol. 2013; 62(18_S1):B157-B157.

doi:10.1016/j.jacc.2013.08.1262

Sharifi M, Spagnolo K, Rea et al. Use of dabigatran in upper extremity deep venous

thrombosis following percutaneous endovenous intervention. Vascular Medicine 17 :3,

209;2012.

Sharifi M, Spagnolo K, Lawson D et al. Low Dose Argatroban and tPA in the Treatment of

Massive Iliac and Femoropopliteal Deep Vein Thrombosis. Catheteriz Cardiovasc Interv

Supplement to 79:S 29;2012.

Sharifi M , Skrocki L, Bay C et al. Reduction in the Duration of Parenteral Anticoagulation

for Deep Venous Thrombosis in Patients Undergoing Percutaneous Endovenous Intervention

and Receiving Dabigatran. Catheteriz Cardiovasc Interv Supplement to 79:S 37;2012.

Sharifi M, Bay C, Schuster T et al. Dabigatran in deep venous thrombosis refractory to

warfarin. J Am Coll Cardiol 59:13,Supplement A, P.A 416;2012.

Sharifi M, Niazi T, Mehdipour M, Emrani E. Efficacy of Viabahn Stents in the

Femoropopliteal Venous Segments in the Treatment of Deep Venous Thrombosis. J Am Coll

Cardiol 57:14,Supplement A, P.110;2011.

Sharifi M, Mehdipour M, Niazi T et al. Natural History of Venous Stents Implanted During

Percutaneous Endovenous Intervention for Deep Venous Thrombosis. Catheteriz Cardiovasc

Interv Supplement to 77:S 53;2011.

Sharifi M, Mehdipour M, Niazi T et al. Role of Intravascular Ultrasound During

Percutaneous Endovenous Intervention for Deep venous Thrombosis. Catheteriz Cardiovasc

Interv Supplement to 77:S 53;2011.

Sharifi M, Patel R, Niazi T, Emrani E , Mehdipour M. Peripheral Blood Gene Expression in

Patients with and without Coronary Artery Disease. J Am Coll Cardiol 57:14,Supplement A,

P.80;2011.

Sharifi M,Smith G,Bay C, Mehdipour M, Sharifi J. Percutaneous Endovenous

intervention reduces Recurrent Venous Thromboembolic and Post Thrombotic Syndrome in

acute DVT:- Report of the TORPEDO Trial at Mid-Term Follow up. J Am Coll Cardiol

56:13,XV;2011 Late Breaking Trials.

Sharifi M, Mehdipour M. Berkovits A, Smith G Percutaneous Endovenous Intervention

Reduces Post Thrombotic Syndrome and Recurrent Venous Thromboembolic Disease in

Patients with Acute DVT. J Am Coll Cardiol 55: 10, A 180, 2010.

Sharifi M, Mehdipour M. Berkovits A, Bay C, Smith G. Low Restenosis Rate of Stents

Placed in Peripheral Venous Circulation. Catheteriz Cardiovasc Interv May 2010.

Sharifi M , Mehdipour M, Smith G, Starling M, Tarlian H. Reduction Of Post-Thrombotic

Syndrome in Acute Deep Venous Thrombosis by Power Pulse Spray and Angiojet

Thrombectomy Catheteriz Cardiovasc Interv June 2009

Sharifi M , Mehdipour M, Smith G, Starling M, Differences In PFO Morphology In Patients

With And Without Neurologic Events. Catheteriz Cardiovasc Interv June 2009

Sharifi M, Fares W, Abdel-Karim I, et al. Hyperbaric Oxygen Therapy in Percutaneous

Coronary Interventions: The Interim Results. Catheter Cardiovasc Interv 25: 130-131, 2003

Sharifi M, Hedayat M, Perouyan J, Mehdipour M et al. Incidental Pathologic findings on

coronary and aortic multislice computed tomography. Catheteriz and Cardiovasc Interv

66:820, 2006.

Sharifi M, Al-Bustami O, Mehdipour M et al. Necessity for evaluation of partial anomalous

pulmonary venous return prior to percutaneous closure of interatrial shunts in adults.

Catheteriz and Cardiovasc Interv [abstract A- 29] 65: 96, 2005.

Sharifi M, Dehghani M, Mehdipour M et al. Treatment of migraines post percutaneous

closure of atrial shunts: A new indication for clopidogrel. Catheteriz and Cardiovasc Interv

[abstract A- 27], 65:95, 2005.

Sharifi M, Fares W, Abdel-Karim I,et al. Reduction of restenosis in percutaneous coronary

interventions by hyperbaric oxygen therapy. J Am Coll Cardiol 2003; 41:17A.

Sharifi M, Koch JM, Petrea D, et al. Hyperbaric oxygen therapy to inhibit restenosis in

percutaneous coronary interventions: a preliminary report. Catheter Cardiovasc Interv

2002;56:136.

Sharifi M, Abdel-Karim A, Petrea D, et al. Hyperbaric oxygen therapy reduces restenosis in

percutaneous coronary interventions. Am J Cardiol 2002; 24:12 H.

Late Breaking Clinical Trials:

Moderate Pulmonary Embolism Treated with Thrombolysis: MOPETT

Trial. Late Breaking Clinical Trial. ACC/i2 61st Annual Scientific

Session, Chicago, IL, March 2011.

Endovenous Infra-Inguinal Stenting and Angioplasty in Deep

Venous Thrombosis Trial EVISTA-DVT Trial- Late Breaking Clinical

Trial. Society for Cardiac Angiography and Interventions, 24th annual

meeting. Baltimore, MD , May 2011.

Filter Implantation to Lower Thromboembolic Risk in Percutaneous

Endovenous Intervention ( FILTER-PEVI Trial)- Late Breaking Clinical

Trial ACC/i2 60th

Annual Scientific Session, New Orleans, LA, April

2011.

TORPEDO Trial. Late Breaking Clinical Trial.TCT 2010. Washington

D.C.

National & International Presentations:

Target Specific Oral Anticoagulants Following Percutaneous Endovenous

Intervention for Lower Extremity Deep Venous Thrombosis in Patients

with Cancer. CVC, 6 Annual Meeting, July 2016, Chicago, IL.

DVT in the Patient with Concomitant Arterial Disease. CVC, 6 Annual

Meeting, July 2016, Chicago, IL.

Advanced Interventional Techniques for DVT with Angiojet Zelante DVT

and Penumbra. CVC, 6 Annual Meeting, July 2016, Chicago, IL.

Abdominal Aortic Endoluminal Grafts and Subsequent Laparascopic

Abdominal Surgery Promotes Extensive Deep Vein Thrombosis. Society

for Cardiac Angiography and Interventions, 29th annual meeting,

Orlando, Fl. May 2016.

Outcome of Life Star Stents in the Venous Circulation. Society

for Cardiac Angiography and Interventions, 29th annual meeting,

Orlando, Fl. May 2016.

Treatment of Massive Pulmonary Embolism During Cardio- Pulmonary

Collapse and Pulseless Electrical Activity With Low Dose Systemic

Thrombolysis. Society for Vascular Medicine 27 Annual Meeting and

Scientific Sessions, Long Beach, CA, June 2016

Debate: PERT Teams Complicate the Care of Patients with PE. Society

for Vascular Medicine 27 Annual Meeting and Scientific Sessions, Long

Beach, CA, June 2016

Role Of Wallstents In The Treatment Of Chronic Inferior Vena Cava

Filter Occlusion TCT October 2015, San Francisco CA.

New Oral Anticoagulants in Reduction of Post-Thrombotic Syndrome in

Patients undergoing PEVI. New Cardiovascular Horizons, 16 Annual

Meeting, New Orleans, LA, May 2015.

Treatment of Chronic Inferior Vena Cava Filter Occlusion with Wall

Stents. Society for Cardiac Angiography and Interventions, 28th annual

meeting. San Diego, CA , May 2015.

The Year in Vascular Medicine: Venous Thromboembolism.

Society for Vascular Medicine 26 Annual Meeting and Scientific

Sessions, Baltimore, MD, June 2015.

Vascular Emergencies: Pulmonary Embolism.

Society for Vascular Medicine 26 Annual Meeting and Scientific

Sessions, Baltimore, MD, June 2015.

Role of Apixaban in Dialysis Patients after Percutaneous Endovenous

Intervention for Deep Venous Thrombosis of the Lower Extremities,

Society for Vascular Medicine 26 Annual Meeting and Scientific

Sessions, Baltimore, MD, June 2015

The Use of New-Generation Anticoagulations in DVT & PE: What are the

Current Indications? How to Address Negative Commercial Ads with

Your Patient CVC, 5 Annual Meeting, July 2015, Chicago, IL.

Challenging Case Presentations with Expert Panel Discussion. CVC, 5

Annual Meeting, July 2015, Chicago, IL.

Percutaneous Endovenous Intervention in Cancer Patients with Deep

Venous Thrombosis of the Lower Extremities. ACC/i2 64 th Annual

Scientific Session, San Diego, CA, March 2015.

Treatment of Pulmonary Embolism: Debates; ACC/i2 64 th Annual

Scientific Session, San Diego, CA, March 2015.

New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous

Endovenous Intervention for Lower Extremity Deep Venous Thrombosis,

TCT 2014, Washington DC.

Endovascular Therapy or Anticoagulation for DVT: Results of the

TORPEDO Trial, CVC 2014, Chicago, IL.

Laceration of Popliteal Vein Treated with Covered Stents. Society for

Vascular Medicine 2014 Annual Meeting and Scientific Sessions, La Jolla

, CA.

Paradigm shift in the treatment of PE:Updates on the MOPETT,

PEITHO, TOPCOAT AND ULTIMA Trials. Society for

Vascular Medicine 2014 Annual Meeting and Scientific Sessions, La Jolla

, CA.

Role of New Oral Anticoagulants in the Treatment of Superficial

Venous Thrombosis of the Lower Extremities. Society for

Vascular Medicine 2014 Annual Meeting and Scientific Sessions, La Jolla

, CA.

Anticoagulant and antiplatelet therapy cocktails after acute and chronic

DVT intervention - my current practice. Society for Cardiac Angiography

and Interventions, 27th annual meeting. Las Vegas, NV, May 2014.

Limited Role of Thrombectomy Devices Alone for Occlusive IVC Filter

Thrombosis. Society for Cardiac Angiography and Interventions, 27th

annual meeting. Las Vegas, NV, May 2014.

Percutaneous Endovenous Intervention and New Oral Anticoagulants

Reduce Post- Thrombotic Syndrome in Acute Deep Venous

Thrombosis. Society for Cardiac Angiography and Interventions, 27th

annual meeting. Las Vegas, NV, May 2014.

Half dose Fibrinolysis in Pulmonary Embolism: Focus on MOPETT.

ACC/i2 63rd Annual Scientific Session, Washington DC, March 2014.

Treatment of Heparin Induced Thrombocytopenia with New Oral

Anticoagulants. ACC/i2 63rd Annual Scientific Session, Washington DC,

March 2014.

Paradigm Shift in the Treatment of Pulmonary Embolism. ACC/i2 63rd

Annual Scientific Session, Washington DC, March 2014.

Modern Management of DVT. iCON, Scottsdale, AZ, 2014.

Role of Rivaroxaban in the Treatment of Venous Thromboembolic

Disease Associated With Cancer. ICCAD, Florence, Italy 2013.

Which Patients Should Have a Prophylactic IVC Filter Placed During

Catheter Based Treatment of Large Vein Clots: Based on a Randomized

Clinical Trial: The FILTER-PEVI Study. VEITH Symposium 2013, NY,

NY.

Efficacy of Rivaroxaban in Cancer-Related Venous Thromboembolic

Disease. ISET, Miami, FL, January 2014.

Reduction of Hospitalization and Duration of Anticoagulation for Deep

Venous Thrombosis in Patients Undergoing Percutaneous Endovenous

Intervention and Receiving Novel Anticoagulants. TCT 2013, San

Francisco, CA.

Argatroban and t-PA During Catheter-Directed thrombolysis for Extensive

lower Extremity Deep Venous Thrombosis. TCT 2013, San Francisco,

CA.

IVC Filters: Current indications and retrieval. New Cardiovascular

Horizons , New Orleans, LA, June 2013.

Deep Venous Thrombosis: Diagnosis & Management Considerations.

New Cardiovascular Horizons , New Orleans, LA, June 2013.

Modern Medical Management of Venous thrombosis:

New Drugs, New Strategies. Society for Cardiac

Angiography and Interventions, 26th annual meeting.

Orlando, Fl, May 2013.

Interventional Management for Iliofemoral Deep Venous Thrombosis

ACC/i2 62nd Annual Scientific Session, San Francisco, CA, March 2013.

DVT: Medical Therapy versus Endovascular Therapy ACC/i2 62nd

Annual Scientific Session, San Francisco, CA, March 2013.

Percutaneous Endovenous Intervention for DVT. iCON,

Scottsdale, AZ, 2013.

Shorter Duration of Anticoagulation for Deep Venous Thrombosis in

Patients Undergoing Percutaneous Endovenous Intervention and

Receiving Rivaroxaban and Dabigatran. iCON, Scottsdale, AZ, 2013.

Role of Rivaroxaban in Patients Undergoing Percutaneous Endovenous

Intervention for Massive Lower Extremity Deep Venous Thrombosis.

Society for Cardiac Angiography and Interventions, 26th annual meeting.

Orlando, Fl, May 2013.

Treatment of Occlusive IVC Filter Thrombosis by Percutaneous

Endovenous Intervention. Society for Cardiac Angiography and

Interventions, 26th annual meeting. Orlando, Fl, May 2013.

Upper Extremity Venous Reconstruction for Chronic Venous Occlusive

Disease. ISET, Miami, FL, January 2013.

Filter or No Filter for DVT Lysis? ISET, Miami, FL, January 2013.

Venous Stenting. ISET, Miami, FL, January 2013.

Synergistic Effects of Low Dose Argatroban and tPA During

Catheter Directed Thrombolysis for Massive Iliac and

Femoropopliteal Deep Vein Thrombosis. ISET, Miami, FL, January 2013.

Outcome of Stenting in the Subclavian Vein for Upper Extremity Edema.

ISET, Miami, FL, January 2013.

Debate : Pro. Percutaneous Endovenous intervention with Emphasis on

CDT for Acute Iliofemoral DVT. American College of

Phlebology, 26 Annual Congress, Hollywood, Fl, November 15-18, 2012

Coumadin Resistance and Massive Bilateral DVT. American College of

Phlebology, 26 Annual Congress, Hollywood, Fl, November 15-

18, 2012

Percutaneous Endovenous Intervention for Occlusive IVC Filter

Thrombosis. American College of Phlebology, 26 Annual Congress,

Hollywood, Fl, November 15-18, 2012

Role of Trellis Catheter in the Treatment of IVC Filter Thrombosis.TCT

2012, Miami, Fl, October 22-26, 2012.

Use of Dabigatran in Upper Extremity Deep Venous Thrombosis

Following Percutaneous Endovenous Intervention. Society for vascular

Medicine 23rd Annual Scientific Sessions, June 2012 Minneapolis, MN.

IVC Filters: Types, Indications and retrieval. New Cardiovascular

Horizons , New Orleans, LA, June 2012.

Role of IVC Filters in Endovenous Therapy for DVT. Fifth Razavi

International Cardiovascular Surgery Congress. Mashhad, Iran,June 2012

Low Dose Argatroban and tPA in the Treatment of Massive Iliac and

Femoropopliteal Deep Vein Thrombosis. Society for Cardiac Angiography

and Interventions, 25th annual meeting. Las Vegas, NV, May 2012.

Reduction in the Duration of Parenteral Anticoagulation for Deep Venous

Thrombosis in Patients Undergoing Percutaneous Endovenous

Intervention and Receiving Dabigatran. Society for Cardiac Angiography

and Interventions, 25th annual meeting. Las Vegas, NV, May 2012.

Dabigatran in Deep Venous Thrombosis Refractory to Warfarin. ACC/i2

61st Annual Scientific Session, Chicago, IL, March 2011.

Debate- Con: Primary Stenting is the Treatment of Choice for Acute DVT.

ACC/i2 61st Annual Scientific Session, Chicago, IL, March 2011.

Deep Venous Thrombosis: Optimal Patient Selection and techniques for

Endovascular Interventions. ACC/i2 61st Annual Scientific Session,

Chicago, IL, March 2011.

Percutaneous Endovenous Intervention for Upper Extremity Deep

Venous Thrombosis. ISET, Miami, FL, January 2012.

Results of the Endovenous Infrainguinal Stenting Trial for DVT. TCT

San Francisco, CA, November 2011.

Venous Disease in Podiatry. Desert Foot Conference, Phoenix, AZ,

November 2011.

The TORPEDO Trial. New Cardiovascular Horizons , New Orleans, LA,

June 2011

Headaches Associated with Diseases of the Atrial Septum. The 15th

Congress of the International Headache Society Berlin, Germany, June

2011.

Outcome of stenting in the Lower Extremity Venous Circulation for the

Treatment of DVT. 21st World Society of Cardiothoracic surgery Berlin,

Germany, June 2011.

Natural History of Venous Stents Implanted During Percutaneous

Endovenous Intervention for Deep Venous Thrombosis. Society for

Cardiac Angiography and Interventions, 24th annual meeting. Baltimore,

MD , May 2011.

Role of Intravascular Ultrasound During Percutaneous Endovenous

Intervention for Deep venous Thrombosis. Society for Cardiac

Angiography and Interventions, 24th annual meeting. Baltimore,

MD , May 2011.

Efficacy of Viabahn Stents in the Femoropopliteal Venous Segments in

the Treatment of Deep Venous Thrombosis. ACC/i2 60th

Annual

Scientific Session, New Orleans, LA, April 2011.

Treatment of Massive Combined Subclavian and Jugular Vein Deep

Venous Thrombosis by Percutaneous Endovenous Intervention. Case

presentation. ACC/i2 60th

Annual Scientific Session, New Orleans, LA,

April 2011.

Peripheral Blood Gene Expression in Patients with and without Coronary

Artery Disease. ACC/i2 60th

Annual Scientific Session, New Orleans, LA,

April 2011.

The "TORPEDO" Approach in the Treatment of Deep Venous

Thrombosis. Cardiovascular Innovations. CRT, Washington DC, March

2011.

Very Low Bleeding Rates with Local Thrombolytic Therapy Given

During Percutaneous Endovenous Intervention for the Treatment of Deep

Venous Thrombosis. CRT, Washington DC, March 2011.

Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention

in Deep Venous Occlusion- Oral presentation-24 Annual Congress ,

American College of Phlebology, Nov 6 2010 Orlando, FL.

Percutaneous Endovenous Intervention Reduces Post Thrombotic

Syndrome and Recurrent Venous Thromboembolic Disease in Patients

with Acute DVT. ACC/i2 59th

Annual Scientific Session, Atlanta,

Georgia, 2010.

Low Restenosis Rate of Stents Placed in Peripheral Venous Circulation.

Society for Cardiac Angiography and Interventions 23rd annual meeting.

San Diego, CA, May 2010.

Determination of the Appropriate Transcatheter Endovenous Tissue

Plasminogen Activator Dose for the Treatment of Extensive Acute

Proximal DVT. CRT 2010, Washington DC.

Power Pulse Spray and Angiojet Atherectomy in Massive Pulmonary

Embolism. ISET 2010, Hollywood, Florida.

Differences in PFO Morphology in Patients with and without Neurologic

Events. Society for Cardiac Angiography and Interventions 22nd annual

meeting. Las Vegas, NV, June 2009.

Reduction of Post-Thrombotic Syndrome in Acute Deep Venous

Thrombosis by Power Pulse Spray and Angiojet Thrombectomy. Society

for Cardiac Angiography and Interventions. 22nd annual meeting. Las

Vegas, NV, June 2009.

Incidental Pathologic findings on coronary and aortic multislice computed

tomography. Society for Cardiac Angiography and Interventions 29th

annual meeting. Chicago, IL , May 2006.

Treatment of migraines post ASD closure with clopidogrel.

Society for Cardiac Angiography and Interventions 28th

annual

meeting, Ponte Vedra, FL, May 2005

Evaluation of PAPVR prior to closure of interatrial shunts.

SCA&I Society for Cardiac Angiography and Interventions 28th

annual meeting, Ponte Vedra, FL, May 2005

Reduction of Clinical Restenosis by Hyperbaric Oxygen Therapy.TCT

2003, Washington D.C. September 2003

Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions: The

Interim Results. Society for Cardiac Angiography and Interventions, 26th

Annual Session, Boston, MA, May 2003

Reduction of Restenosis in Percutaneous Coronary Interventions by

Hyperbaric Oxygen Therapy ACC March 2003, Chicago, IL 2003

Hyperbaric Oxygen Therapy: A Novel Strategy to Combat

Restenosis.CRT 2003 Washington D.C. January 2003

Hyperbaric Oxygen Therapy to Inhibit Restenosis in Percutaneous

Coronary Interventions. Society for Cardiac Angiography and

Interventions, 25th Annual Session, Seattle, WA May2002

Hyperbaric Oxygen Therapy Reduces Restenosis in Percutaneous

Coronary Interventions. TCT 2002, Washington D.C. September

2002

Scientific Interviews

( available on-line) :

Mohsen Sharifi

http://scivee-1.sdsc.edu/node/47327

European Heart Journal- My Cardio Interview: G. Hindricks with M. Sharifi on The MOPETT Trial | SciV

scivee-1.sdsc.edu

G. Hindricks in conversation with M. Sharifi: The MOPETT Trial

Like · · Share · 9 minutes ago · Mohsen Sharifi

http://www.theheart.org/article/1377765.do

Debate on whether half-dose tPA could be used to treat moderate PE | theheart.org

www.theheart.org

New results from a pilot trial suggest that a half dose of the thrombolytic tPA, in combination with a reduced anticoagulation regime, could be used to successfully

treat around 70% of patients presenting to the emergency room with pulmonary embolism, resulting in improved outcomes with no severe ad...

Like · · Share · March 27 at 9:43pm ·

Mohsen Sharifi

http://www.theheart.org/podcast/video/trials-and-pis/new-post-2-5.do

MOPETT with Dr Mohsen Sharifi | theheart.org

www.theheart.org

The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for

free.

Like · · Share · March 27 at 9:42pm ·

Medical News: TORPEDO Trial: Mohsen Sharifi, MD - in Meeting Coverage, TCT from MedPage Today

www.medpagetoday.com

Mohsen Sharifi

TCT Video: Sharifi aims to TORPEDO DVT via PEVI www.cardiovascularbusiness.com

WASHINGTON, D.C.—Principal Investigator Mohsen Sharifi, MD, of the Arizona Cardiovascular Consultants and Vein clinic and professor at A.T. Still University in Mesa, Ariz., reviews the results of the TORPEDO (Thombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion...

http://www.medpagetoday.com/MeetingCoverage/SCAI/26349

Medical News: SCAI: Stenting OK for Deep Vein Thrombosis - in Meeting Coverage, SCAI from MedPage To

www.medpagetoday.com BALTIMORE — Stenting i

Login www.cardiosource.org

A CardioSource subscription will advance your career and enhance your practice by providing you all the resources you need - on one comprehensive website.

http://www.clinicaltrialresults.org/ Clinical Trial Results: The International Leader in Medical Media www.clinicaltrialresults.org

http://www.crtonline.org/CardioTube/Default.aspx

ACC 2014 Interview on Safe Dose Thrombolysis for PE: http://landing.quadia.nl/video/medtalks/?m=131530